NIA: Alzheimer's Biomarker Tests Suited for Research, Not Clinic

The National Institute on Aging /Alzheimer's Association Guidelines for Alzheimer's Disease sees biomarker use in the clinic as a future prospect.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.